Dr. Joseph Joyce, Director, Vaccine Research, Merck Research Laboratories, to Deliver Featured Speech at 9th Annual Vaccines Discovery and Development: All Things Considered Conference (Nov. 7-8, 2011, in Boston, MA)
Dr. Joseph Joyce will discuss M-Protein-derived peptide conjugate vaccine candidates for Streptococcus pyogenes. Group A Streptococcus (GAS) infections caused by S. pyogenes represent a major health care burden in both developed and developing nations. Disease etiology ranges from mild pharyngitis to life-threatening manifestations such as necrotizing fasciitis and toxic shock syndrome. In a percentage of individuals, post-infection sequelae can lead to serious autoimmune manifestations such as rheumatic fever and glomerulonephritis. While first line antibiotics are generally effective, recurrent infection and...
View full press release